[CAS NO. 1221485-83-1]  Skepinone-L

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1221485-83-1]

Store
Catalog
SLK-S7214
Brand
Selleck
CAS
1221485-83-1

DESCRIPTION [1221485-83-1]

Overview

MDLMFCD22572738
Molecular Weight425.42
Molecular FormulaC24H21F2NO4
SMILESO=C1C2=CC=C(NC3=CC=C(F)C=C3F)C=C2CCC4=CC=C(OC[C@H](O)CO)C=C14

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.3506 mL11.7531 mL23.5062 mL
5 mM0.4701 mL2.3506 mL4.7012 mL
10 mM0.2351 mL1.1753 mL2.3506 mL
50 mM0.0470 mL0.2351 mL0.4701 mL

Description

Skepinone-L (CBS3830) is a selective inhibitor with of 5 nM.

Targets

p38α [1]
5 nM

In vitro

Skepinone-L shows concentration-dependent inhibition of HSP27 (Ser82) phosphorylation through the p38 MAPK pathway with a cellular IC50 of approximately 25 nM, and also reduces concentrations of TNF-α, IL-1β and IL-10, regulated by p38 MAPK, with IC50 ranging from 30 to 50 nM . Skepinone-L (1 μM) abrogates the phosphorylation of platelet p38 MAPK substrate Hsp27 activated by stimulation with CRP, thrombin or thromboxane A2 analogue U-46619, and impairs platelet secretion and aggregation.

In vivo

In vivo, skepinone-L inhibits Gal/ LPS-induced TNF-α release by 77%.